Intellectual Property Magazine
Will Gilead find an antidote?
Gilead’s attempt to invalidate a US government patent hits a stumbling block, while a Chinese government entity seeks to patent its Coronavirus ‘cure’
Ben Wodecki
Gilead Sciences has failed in its attempt to invalidate US government-owned patents related to HIV prevention, which it is
accused of infringing.